Dr. Mehta's clinical trial prelim. results announced-
Re: Dr. Mehta's clinical trial prelim. results announced-
I have been also waiting for results of this Albany teams's research.. patience, patience..
My wife's 3 yrs post video: http://www.youtube.com/watch?v=eLeqLps8XR8
Our family: http://www.youtube.com/watch?v=p_QCKxeQAlg
Our family: http://www.youtube.com/watch?v=p_QCKxeQAlg
Re: Dr. Mehta's clinical trial prelim. results announced-
My neuro said that this study is a means to an end - the end being $$$$.
A clinical study does not charge each patient $6K, with a 66% chance of having it done - if not, your $6K gets flushed down the toilet into Dr. Mehta's pocket!
Interesting disguise...I can't wait to see what other's will come up with!!
A clinical study does not charge each patient $6K, with a 66% chance of having it done - if not, your $6K gets flushed down the toilet into Dr. Mehta's pocket!
Interesting disguise...I can't wait to see what other's will come up with!!
Re: Dr. Mehta's clinical trial prelim. results announced-
Is that true? I'll look it up. I believe the trial lasts for a year and then at the end of the year, anyone in the sham group would get the real treatment.hargarah wrote:A clinical study does not charge each patient $6K, with a 66% chance of having it done - if not, your $6K gets flushed down the toilet into Dr. Mehta's pocket!
CCSVI research is underfunded..... Dr. McDonald's study, which uses ultrasounds which are much, much cheaper than a procedure, has not been funded, so that also is patient-paid at $250 an ultrasound.
With funding, there is the ethical issue that only patients who can afford it are taking the risks of getting CCSVI treatment early, and those who cannot afford it are benefitting from the risks taken by those who can. There is also the ethical issue that the potential benefits of the procedure are only available to those who can afford it.
With funding, there is the bigger societal ethical issue that the pharmaceutical companies have deep pockets to investigate pharmaceutical treatments, and that promising simpler solutions such as LDN go untested for lack of funding.
Re: Dr. Mehta's clinical trial prelim. results announced-
"With funding, there is the ethical issue that only patients who can afford it are taking the risks of getting CCSVI treatment early"
The rich take the risk for a change.One of the hazards of having money is youu can use it to do risky things.
The rich take the risk for a change.One of the hazards of having money is youu can use it to do risky things.